Transplantation Market Size, Share & Trends Analysis Report By Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), By Application (Organ, Tissue Transplant), By End Use, And Segment Forecasts, 2023 - 2030
- Report ID: GVR-1-68038-864-0
- Number of Pages: 110
- Format: Electronic (PDF)
- Historical Range: 2018 - 2021
- Industry: Healthcare
Market Segmentation
- Transplantation Market Product outlook (Revenue, USD Million, 2018 - 2030)
- Tissue products
- Immunosuppressive drugs
- Preservation solution
- Transplantation Market Application outlook (Revenue, USD Million 2018 - 2030)
- Organ transplantation
- Tissue transplantation
- Transplantation Market End Use (Revenue USD Million, 2018 - 2030)
- Hospitals
- Transplantation Centers
- Others
- Transplantation Market Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America transplantation market, by product type
- Tissue products
- Immunosuppressive drugs
- Preservation solution
- North America transplantation market, by application type
- Organ transplantation
- Tissue transplantations
- North America transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- U.S.
- U.S. transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- U.S. transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- U.S. transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- U.S. transplantation market, by product type
- Canada
- Canada transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Canada transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Canada transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Canada transplantation market, by product type
- North America transplantation market, by product type
- Europe
- Europe transplantation market, by product type
- Tissue products
- Immunosuppressive drugs
- Preservation solution
- Europe transplantation market, by application type
- Organ transplantation
- Tissue transplantations
- Europe transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- U.K.
- U.K. transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- U.K. transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- U.K. transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- U.K. transplantation market, by product type
- Germany
- Germany transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Germany transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Germany transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Germany transplantation market, by product type
- France
- France transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- France transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- France transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- France transplantation market, by product type
- Italy
- Italy transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Italy transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Italy transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Italy transplantation market, by product type
- Spain
- Spain transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Spain transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Spain transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Spain transplantation market, by product type
- Denmark
- Denmark transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Denmark transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Denmark transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Denmark transplantation market, by product type
- Sweden
- Sweden transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Sweden transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Sweden transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Sweden transplantation market, by product type
- Norway
- Norway transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Norway transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Norway transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Norway transplantation market, by product type
- Europe transplantation market, by product type
- Asia Pacific
- Asia Pacific transplantation market, by product type
- Tissue products
- Immunosuppressive drugs
- Preservation solution
- Asia Pacific transplantation market, by application type
- Organ transplantation
- Tissue transplantations
- Asia Pacific transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- China
- China transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- China transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- China transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- China transplantation market, by product type
- Japan
- Japan transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Japan transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Japan transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Japan transplantation market, by product type
- India
- India transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- India transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- India transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- India transplantation market, by product type
- Australia
- Australia transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Australia transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Australia transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Australia transplantation market, by product type
- South Korea
- South Korea transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- South Korea transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- South Korea transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- South Korea transplantation market, by product type
- Thailand
- Thailand transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Thailand transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Thailand transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Thailand transplantation market, by product type
- Asia Pacific transplantation market, by product type
- Latin America
- Latin America transplantation market, by product type
- Tissue products
- Immunosuppressive drugs
- Preservation solution
- Latin America transplantation market, by application type
- Organ transplantation
- Tissue transplantations
- Latin America transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Brazil
- Brazil transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Brazil transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Brazil transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Brazil transplantation market, by product type
- Mexico
- Mexico transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Mexico transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Mexico transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Mexico transplantation market, by product type
- Argentina
- Argentina transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Argentina transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Argentina transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Argentina transplantation market, by product type
- Latin America transplantation market, by product type
- MEA
- MEA transplantation market, by product type
- Tissue products
- Immunosuppressive drugs
- Preservation solution
- MEA transplantation market, by application type
- Organ transplantation
- Tissue transplantations
- MEA transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- South Africa
- South Africa transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- South Africa transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- South Africa transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- South Africa transplantation market, by product type
- Saudi Arabia
- Saudi Arabia transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Saudi Arabia transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Saudi Arabia transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Saudi Arabia transplantation market, by product type
- UAE
- UAE transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- UAE transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- UAE transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- UAE transplantation market, by product type
- Kuwait
- Kuwait transplantation market, by product type
- Tissue Products
- Immunosuppressive drugs
- Preservation solutions
- Kuwait transplantation market, by application type
- Organ transplantation
- Tissue transplantation
- Kuwait transplantation market, by end use
- Hospitals
- Transplantation centers
- Others
- Kuwait transplantation market, by product type
- MEA transplantation market, by product type
- North America
Transplantation Market Dynamics
Driver: Increasing incidence of organ failure
Serious organ failure is associated with acute illnesses that are associated with degradation of organ functioning. Some of the primary causes of organ failure include serious trauma, sepsis, loss of blood, poisoning, drug abuse, leukemia, and other acute illnesses. Further, glomerular diseases, diabetes, hypertensive nephrosclerosis may result in kidney failure. Similarly, cirrhosis leads to liver failure and likewise coronary heart disease may lead to heart failure. Obesity, alcohol & drug abuse, and smoking may lead to such conditions, which could ultimately result in organ failure. Thus, global demand for tissue and organ transplantation, mainly for bone marrow, heart, liver, kidney, and lungs is very high. According to the U.S. Government Information on Organ Donation and Transplantation, about 112,000 candidates were registered on the U.S. national transplant waiting list by March 2020. Increase in the number of geriatric population due to improved & advanced healthcare facilities have also contributed to the high demand for organ transplantation. Thus, increase in number of acute illnesses and rise in the number of geriatric population are factors leading to an increase in number of organ failures globally, thereby propelling the demand for organ transplantation procedures.
Driver: Technological advancements in organ transplant methods
Advanced technologies have led to evolution in organ transplantation techniques and procedures, which is expected to propel the market growth. Novel and improved transplantation products including tissue products, tissue typing technology and surgical medical instruments can be attributed to market expansion. Developments in PCR technique, such as improvements in system design and advanced assays, provide high precision and effectiveness in tissue typing. The development of a new technique by John Hopkins University School of Medicine called desensitization has made it possible to allowing transplanting kidney from any donor. Therapeutic hypothermia has become crucial in organ transplantation utilizing targeted temperature management, which is used to protect neurological functions in patients with cardiac arrest, asphyxia, and stroke. Thus, introduction of such advanced techniques has led to growth of the transplantation market driving the number of organ transplant procedures globally.
Technological advancements in the field of 3D bioprinting are also boosting the adoption of organ transplantation. The continuous shortage of organ donors and increasing number of patients on waiting list for organ transplant have increased the demand for 3D bioprinting. These techniques are used to create customize prosthetics, fabricate tissue, and to support transplantation through synthetic models. However, vascularization of larger tissue structure remains a challenge, and the development of full functional 3D-printed organ is anticipated in a few years.
Restraint: Transplant rejection
Transplant rejection is a process in which the receiver’s immune system attacks the transplanted organ or tissue, identifying the transplanted organ or tissue to be foreign. Typically, three types of rejections are reported-hyper-acute rejection, acute rejection, and chronic rejection. Despite donor matching, tissue typing, and usage of immunosuppressants, there are instances where transplants are rejected by an individual’s body resulting in failure of the organ transplanted. Not adhering to immunosuppressive drugs is one of the major reasons that results in transplant rejection. Possible complications that may arise due to transplant rejection are certain types of cancers, infections, loss of function in transplanted tissue or organ, and severe side effects due to inappropriate medicinal dosages. According to the Organ Procurement and Transplantation Network, failure of transplanted kidney is reported in about 4% of deceased donor kidney transplants within a period of 1 year. In living donor kidney transplant recipients, failure rates are 14% at 5 years after transplant. Thus, with such factors causing transplant rejection, the growth of the market is expected to be hindered.
What Does This Report Include?
This section will provide insights into the contents included in this transplantation market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Transplantation market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Transplantation market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
